AHF Warns Pharma Its Attacks on 340B Drug Program Will Harm Patients
AIDS Healthcare Foundation ( AHF ) condemns the latest series of attempts by drug manufacturers to undermine an essential part of the healthcare safety net, the 340B Drug Pricing Program .
- AIDS Healthcare Foundation ( AHF ) condemns the latest series of attempts by drug manufacturers to undermine an essential part of the healthcare safety net, the 340B Drug Pricing Program .
- Make no mistake, the 340B Program is under attack, said Tracy Jones, AHF senior manager and executive director of the AIDS Task Force of Greater Cleveland, an AHF affiliate.
- Finally, drug companies are trying to convert the program from a discount program into a rebate program.
- Its no secret that drug companies dont like the 340B program, because providing discounts to safety net providers eats into their profits.